Groupe la Francaise Has $41.88 Million Holdings in Intuitive Surgical, Inc. $ISRG

Groupe la Francaise decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 105,842 shares of the medical equipment provider’s stock after selling 17,378 shares during the quarter. Groupe la Francaise’s holdings in Intuitive Surgical were worth $41,883,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Compass Financial Management LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $30,000. Vermillion Wealth Management Inc. lifted its stake in shares of Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares during the period. Motiv8 Investments LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $34,000. Finally, Evergreen Advisors LLC bought a new stake in Intuitive Surgical in the first quarter valued at approximately $35,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 72 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director directly owned 179 shares of the company’s stock, valued at $70,364.90. This represents a 28.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 11,635 shares of company stock valued at $4,640,172. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Oppenheimer upgraded shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price target for the company in a report on Wednesday, August 12th. Royal Bank Of Canada decreased their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a research report on Monday, July 13th. Bank of America lowered their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. TD Cowen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. Finally, Leerink Partners cut their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $508.68.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $366.70 on Monday. The firm has a 50 day moving average of $381.44 and a 200-day moving average of $428.20. The company has a market cap of $129.55 billion, a price-to-earnings ratio of 42.00, a price-to-earnings-growth ratio of 2.77 and a beta of 1.47. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same period last year, the company posted $1.81 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. Analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.